Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.4B
41M shares
52-week range
$28.25 – $60.08
18% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
www.pahc.comNo one on the platform currently holds PAHC.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 576,735 | $31.9M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-02 | $0.1200 | 2026-09-23 |
| 2026-06-03 | $0.1200 | 2026-06-24 |
| 2026-03-04 | $0.1200 | 2026-03-25 |
| 2025-11-26 | $0.1200 | 2025-12-17 |
| 2025-09-03 | $0.1200 | 2025-09-24 |
| 2025-06-04 | $0.1200 | 2025-06-25 |
| 2025-03-05 | $0.1200 | 2025-03-26 |
| 2024-11-27 | $0.1200 | 2024-12-18 |
| 2024-09-04 | $0.1200 | 2024-09-25 |
| 2024-06-05 | $0.1200 | 2024-06-26 |
No one on the platform has traded PAHC yet.
| 2024-03-05 | $0.1200 | 2024-03-27 |
| 2023-11-28 | $0.1200 | 2023-12-20 |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.5B | +3.3% | $3.34 | $3.19–$3.49 | 10.2× | 3 |
| 2028 | $1.6B | +3.4% | $3.68 | $3.65–$3.71 | 9.2× | 1 |
| 2029 | $1.6B | +3.0% | $4.36 | $4.32–$4.39 | 7.8× | 1 |
| 2030 | $1.7B | +3.0% | $4.83 | $4.79–$4.86 | 7.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-06 | $0.72 | $0.76 | +5.6% |
| 2026-02-04 | $0.69 | $0.87 | +26.1% |
| 2025-11-05 | $0.59 | $0.73 | +23.7% |
| 2025-08-27 | $0.52 | $0.57 | +9.6% |
| 2025-05-07 | $0.52 | $0.63 | +21.2% |
| 2025-02-05 | $0.40 | $0.54 | +35.0% |
| 2024-11-07 | $0.25 | $0.35 | +40.0% |
| 2024-08-28 | $0.34 |
| $0.41 |
| +20.6% |
| $2.1B |
| — |
| BGMBGM Group Ltd. | $0.30 | +3.50% | $114M | — |
| EVOEvotec SE | $2.02 | -7.76% | $718M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$PAHC boy this board is dead. Smashed stock so let’s ride!
View on StockTwits ↗$PAHC Cheap, cheap. PE of 14 ¾, FPE of 10 ¼, PEG of ½, P/S of .93, ROE of 30%.
View on StockTwits ↗Phibro Animal Health Q3 Earnings Call Highlights $PAHC #PhibroAnimalHealth #instantalerts #NASDAQ:PAHC https://www.marketbeat.com/instant-a
View on StockTwits ↗$PAHC Share Price: $58.67 Contract Selected: Dec 18, 2026 $60 Calls Buy Zone: $5.70 – $7.04 Target Zone: $9.15 – $11.18 Potential Upside: 52% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$PAHC Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.59 up 13.46% YoY • Reported revenue of $383.54M up 10.27% YoY
View on StockTwits ↗$PAHC working in from the low 52-53 range in the swing service last week we sold half yesterday in the 58s per rules holding half still
View on StockTwits ↗$PAHC Still going strong, good fundamentals. Adding.
View on StockTwits ↗$PAHC surges 126.9% in the past year – What’s driving this Zacks Rank #1 stock? 🚀 🐾 Strong animal health portfolio + Zoetis integration 💉 Vaccine sales up 13% in the second quarter of fiscal 2026, boosted by Latin America demand 💰 Robust solvency with strategic buybacks & dividends Discover why PAHC is a top pick 👉 https://www.zacks.com/stock/news/2882847/is-pahc-stock-a-solid-investment-opportunity-right-now?cid=sm-stocktwits-2-2882847-body-37109&ADID=SYND_STOCKTWITS_TWEET_2_2882847_BODY_37109
View on StockTwits ↗Is $PAHC a hidden opportunity… or a value trap right now? A closer look is being made into whether the stock truly represents a solid investment opportunity at current levels — a question many investors are asking as they evaluate its risk/reward profile. ⚖️ Full investment breakdown here 👉 https://www.zacks.com/stock/news/2882847/is-pahc-stock-a-solid-investment-opportunity-right-now?cid=sm-stocktwits-2-2882847-teaser-37095&ADID=SYND_STOCKTWITS_TWEET_2_2882847_TEASER_37095
View on StockTwits ↗$PAHC Current Stock Price: $51.87 Contracts to trade: $50.0 PAHC Feb 20 2026 Call Entry: $2.66 Exit: $3.88 ROI: 46% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.